AIRNA
PrivateLast Round
Series B
Apr 1, 2025
Total Funding Raised
$245M
Momentum Score
50 /100
Company Overview
AIRNA is a biotechnology company that pioneers the development of RNA editing therapeutics to treat both rare and common diseases. The company's proprietary RESTORE+™ platform is designed to precisely edit RNA, offering a new class of genetic medicines. AIRNA's lead product candidate, AIR-001, is being developed to treat alpha-1 antitrypsin deficiency (AATD), a genetic disorder affecting the lungs and liver. Founded in 2021, the company is backed by prominent venture capital firms and is advancing its lead program into clinical trials. AIRNA has headquarters in Cambridge, MA, and research operations in Tübingen, Germany.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AIRNA Comps
Public and private peers based on sector, stage, and business model.
AIRNA Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Apr 1, 2025 | ||||
| Series A Extension | Jul 31, 2024 | ||||
| Series A | Sep 19, 2023 |
AIRNA Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Codon Capital | Series A |
| Forbion | Series B |
| ARCH Venture Partners | Series B |
| +ND Capital | Series B, Series A, Series A Extension |
| Venrock Healthcare Capital Partners | Series B |
| +ND Capital Fund (f.k.a. NanoDimension) | Series A Extension |
| ARCH Venture Partners | Series B, Series A Extension, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 22, 2026
Developing new medicines for rare and common diseases, starting with AATD.
- Oct 1, 2025
Niru Subramanian appointed as the new COO.
AIRNA Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about AIRNA's valuation, stock price, and market status.
